The FDA granted Pfizer a breakthrough therapy designation for its group B Streptococcus vaccine candidate for pregnant people to prevent GBS disease in newborns based on its ongoing phase 2 trial. GBS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback